Telogen Effluvium: Is There a Need for a New Classification?
作者信息
Trüeb Ralph M
机构信息
Center for Dermatology and Hair Diseases Professor Trüeb, Wallisellen, Switzerland.
出版信息
Skin Appendage Disord. 2016 Sep;2(1-2):39-44. doi: 10.1159/000446119. Epub 2016 May 21.
Abstract
摘要
相似文献
1
Telogen Effluvium: Is There a Need for a New Classification?
Skin Appendage Disord. 2016 Sep;2(1-2):39-44. doi: 10.1159/000446119. Epub 2016 May 21.
2
Telogen Effluvium: A Review of the Literature.
Cureus. 2020 May 27;12(5):e8320. doi: 10.7759/cureus.8320.
3
Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
J Drugs Dermatol. 2018 Nov 1;17(11):1236-1240.
4
Telogen Effluvium: A Review.
J Clin Diagn Res. 2015 Sep;9(9):WE01-3. doi: 10.7860/JCDR/2015/15219.6492. Epub 2015 Sep 1.
5
Chronic telogen effluvium.
Dermatol Clin. 1996 Oct;14(4):723-31. doi: 10.1016/s0733-8635(05)70398-3.
6
Proposing a Simpler Classification of Telogen Effluvium.
Skin Appendage Disord. 2016 Sep;2(1-2):35-38. doi: 10.1159/000446118. Epub 2016 May 18.
7
Telogen Effluvium: Is There a Need for a New Classification? A Reply.
Skin Appendage Disord. 2018 Jan;4(1):29-30. doi: 10.1159/000463391. Epub 2017 Jul 6.
8
Biotin Deficiency in Telogen Effluvium: Fact or Fiction?
J Clin Aesthet Dermatol. 2020 Mar;13(3):37-40. Epub 2020 Mar 1.
9
'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Br J Dermatol. 2005 Jul;153(1):103-12. doi: 10.1111/j.1365-2133.2005.06608.x.
10
Localized Telogen Effluvium Following Hair Transplantation.
Ann Dermatol. 2018 Apr;30(2):214-217. doi: 10.5021/ad.2018.30.2.214. Epub 2018 Feb 21.
引用本文的文献
1
A Comment on Coronavirus Disease 2019 and the Hair.
Int J Trichology. 2024 Jan-Dec;16(1-6):1-5. doi: 10.4103/ijt.ijt_179_20. Epub 2025 Apr 18.
2
Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases.
J Clin Med. 2023 May 3;12(9):3259. doi: 10.3390/jcm12093259.
3
Microneedling and Its Use in Hair Loss Disorders: A Systematic Review.
Dermatol Ther (Heidelb). 2022 Jan;12(1):41-60. doi: 10.1007/s13555-021-00653-2. Epub 2021 Dec 1.
4
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
JAAD Int. 2021 Dec;5:11-18. doi: 10.1016/j.jdin.2021.07.006. Epub 2021 Aug 3.
5
Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study.
Ochsner J. 2021 Summer;21(2):139-142. doi: 10.31486/toj.20.0025.
6
Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.
An Bras Dermatol. 2020 Jul-Aug;95(4):447-451. doi: 10.1016/j.abd.2020.01.005. Epub 2020 May 6.
7
Telogen Effluvium: Is There a Need for a New Classification? A Reply.
Skin Appendage Disord. 2018 Jan;4(1):29-30. doi: 10.1159/000463391. Epub 2017 Jul 6.
本文引用的文献
1
Scalp dysesthesia related to cervical spine disease.
JAMA Dermatol. 2013 Feb;149(2):200-3. doi: 10.1001/jamadermatol.2013.914.
2
Human hair follicle stem/progenitor cells express hypoxia markers.
J Invest Dermatol. 2013 Aug;133(8):2094-7. doi: 10.1038/jid.2013.113. Epub 2013 Mar 8.
3
Assessing the reliability of the Modified Wash Test.
G Ital Dermatol Venereol. 2011 Aug;146(4):289-94.
4
Seasonality of hair shedding in healthy women complaining of hair loss.
Dermatology. 2009;219(2):105-10. doi: 10.1159/000216832. Epub 2009 Apr 29.
5
No association between serum ferritin levels >10 microg/l and hair loss activity in women.
Dermatology. 2008;217(1):1-6. doi: 10.1159/000118505. Epub 2008 Feb 29.
6
Exogen is an active, separately controlled phase of the hair growth cycle.
J Am Acad Dermatol. 2005 Feb;52(2):374-5. doi: 10.1016/j.jaad.2004.07.040.
7
Kenogen in female androgenetic alopecia. A longitudinal study.
Dermatology. 2005;210(1):18-20. doi: 10.1159/000081477.
8
Diffuse alopecia in women. Its unexplained apparent increase in incidence.
Arch Dermatol. 1960 Apr;81:556-60. doi: 10.1001/archderm.1960.03730040060011.
9
Diffuse cyclic hair loss in women.
Arch Dermatol. 1960 Feb;81:205-7. doi: 10.1001/archderm.1960.03730020041007.
10
Pathologic dynamics of human hair loss. I. Telogen effuvium.
Arch Dermatol. 1961 Feb;83:175-98. doi: 10.1001/archderm.1961.01580080005001.
Zotero 插件